Cargando…

Long-term outcomes of 307 patients after complete thymoma resection

BACKGROUND: Thymoma is an uncommon tumor without a widely accepted standard care to date. We aimed to investigate the clinicopathologic variables of patients with thymoma and identify possible predictors of survival and recurrence after initial resection. METHODS: We retrospectively selected 307 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zu-Yang, Gao, Shu-Geng, Mu, Ju-Wei, Xue, Qi, Mao, You-Sheng, Wang, Da-Li, Zhao, Jun, Gao, Yu-Shun, Huang, Jin-Feng, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/
https://www.ncbi.nlm.nih.gov/pubmed/28506287
http://dx.doi.org/10.1186/s40880-017-0213-8
_version_ 1783236758950903808
author Yuan, Zu-Yang
Gao, Shu-Geng
Mu, Ju-Wei
Xue, Qi
Mao, You-Sheng
Wang, Da-Li
Zhao, Jun
Gao, Yu-Shun
Huang, Jin-Feng
He, Jie
author_facet Yuan, Zu-Yang
Gao, Shu-Geng
Mu, Ju-Wei
Xue, Qi
Mao, You-Sheng
Wang, Da-Li
Zhao, Jun
Gao, Yu-Shun
Huang, Jin-Feng
He, Jie
author_sort Yuan, Zu-Yang
collection PubMed
description BACKGROUND: Thymoma is an uncommon tumor without a widely accepted standard care to date. We aimed to investigate the clinicopathologic variables of patients with thymoma and identify possible predictors of survival and recurrence after initial resection. METHODS: We retrospectively selected 307 patients with thymoma who underwent complete resection at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Beijing, China) between January 2003 and December 2014. The associations of patients’ clinical characteristics with prognosis were estimated using Cox regression and Kaplan–Meier survival analyses. RESULTS: During follow-up (median, 86 months; range, 24–160 months), the 5- and 10-year disease-free survival (DFS) rates were 84.0% and 73.0%, respectively, and the 5- and 10-year overall survival (OS) rates were 91.0% and 74.0%, respectively. Masaoka stage (P < 0.001), World Health Organization (WHO) histological classification (P < 0.001), and postoperative radiotherapy after initial resection (P = 0.006) were associated with recurrence (52/307, 16.9%). Multivariate analysis revealed that, after initial resection, WHO histological classification and Masaoka stage were independent predictors of DFS and OS. The pleura (25/52, 48.0%) were the most common site of recurrence, and locoregional recurrence (41/52, 79.0%) was the most common recurrence pattern. The recurrence pattern was an independent predictor of post-recurrence survival. Patients with recurrent thymoma who underwent repeated resection had increased post-recurrence survival rates compared with those who underwent therapies other than surgery (P = 0.017). CONCLUSIONS: Masaoka stage and WHO histological classification were independent prognostic factors of thymoma after initial complete resection. The recurrence pattern was an independent predictor of post-recurrence survival. Locoregional recurrence and repeated resection of the recurrent tumor were associated with favorable prognosis.
format Online
Article
Text
id pubmed-5433013
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54330132017-05-17 Long-term outcomes of 307 patients after complete thymoma resection Yuan, Zu-Yang Gao, Shu-Geng Mu, Ju-Wei Xue, Qi Mao, You-Sheng Wang, Da-Li Zhao, Jun Gao, Yu-Shun Huang, Jin-Feng He, Jie Chin J Cancer Original Article BACKGROUND: Thymoma is an uncommon tumor without a widely accepted standard care to date. We aimed to investigate the clinicopathologic variables of patients with thymoma and identify possible predictors of survival and recurrence after initial resection. METHODS: We retrospectively selected 307 patients with thymoma who underwent complete resection at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Beijing, China) between January 2003 and December 2014. The associations of patients’ clinical characteristics with prognosis were estimated using Cox regression and Kaplan–Meier survival analyses. RESULTS: During follow-up (median, 86 months; range, 24–160 months), the 5- and 10-year disease-free survival (DFS) rates were 84.0% and 73.0%, respectively, and the 5- and 10-year overall survival (OS) rates were 91.0% and 74.0%, respectively. Masaoka stage (P < 0.001), World Health Organization (WHO) histological classification (P < 0.001), and postoperative radiotherapy after initial resection (P = 0.006) were associated with recurrence (52/307, 16.9%). Multivariate analysis revealed that, after initial resection, WHO histological classification and Masaoka stage were independent predictors of DFS and OS. The pleura (25/52, 48.0%) were the most common site of recurrence, and locoregional recurrence (41/52, 79.0%) was the most common recurrence pattern. The recurrence pattern was an independent predictor of post-recurrence survival. Patients with recurrent thymoma who underwent repeated resection had increased post-recurrence survival rates compared with those who underwent therapies other than surgery (P = 0.017). CONCLUSIONS: Masaoka stage and WHO histological classification were independent prognostic factors of thymoma after initial complete resection. The recurrence pattern was an independent predictor of post-recurrence survival. Locoregional recurrence and repeated resection of the recurrent tumor were associated with favorable prognosis. BioMed Central 2017-05-15 /pmc/articles/PMC5433013/ /pubmed/28506287 http://dx.doi.org/10.1186/s40880-017-0213-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Yuan, Zu-Yang
Gao, Shu-Geng
Mu, Ju-Wei
Xue, Qi
Mao, You-Sheng
Wang, Da-Li
Zhao, Jun
Gao, Yu-Shun
Huang, Jin-Feng
He, Jie
Long-term outcomes of 307 patients after complete thymoma resection
title Long-term outcomes of 307 patients after complete thymoma resection
title_full Long-term outcomes of 307 patients after complete thymoma resection
title_fullStr Long-term outcomes of 307 patients after complete thymoma resection
title_full_unstemmed Long-term outcomes of 307 patients after complete thymoma resection
title_short Long-term outcomes of 307 patients after complete thymoma resection
title_sort long-term outcomes of 307 patients after complete thymoma resection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/
https://www.ncbi.nlm.nih.gov/pubmed/28506287
http://dx.doi.org/10.1186/s40880-017-0213-8
work_keys_str_mv AT yuanzuyang longtermoutcomesof307patientsaftercompletethymomaresection
AT gaoshugeng longtermoutcomesof307patientsaftercompletethymomaresection
AT mujuwei longtermoutcomesof307patientsaftercompletethymomaresection
AT xueqi longtermoutcomesof307patientsaftercompletethymomaresection
AT maoyousheng longtermoutcomesof307patientsaftercompletethymomaresection
AT wangdali longtermoutcomesof307patientsaftercompletethymomaresection
AT zhaojun longtermoutcomesof307patientsaftercompletethymomaresection
AT gaoyushun longtermoutcomesof307patientsaftercompletethymomaresection
AT huangjinfeng longtermoutcomesof307patientsaftercompletethymomaresection
AT hejie longtermoutcomesof307patientsaftercompletethymomaresection